Skip to Content

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Australia’s First Single-Cell Genomics Centre of Excellence Opens at Monash Health Translation Precinct
Through an innovative and entrepreneurial approach to genomics medicine, the Centre intends to accelerate scientific discoveries.   MELBOURNE, Australia and SOUTH SAN FRANCISCO, California, Sept. 4, 2015 – A partnership among Monash University, the University of Melbourne, the University of
View HTML
Toggle Summary Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations
SOUTH SAN FRANCISCO, Calif. , April 23, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Brad Kreger as Senior Vice President, Global Operations. In this role, Kreger leads global manufacturing, supply chain, demand planning, and distribution for
View HTML
Toggle Summary Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring
Mass cytometry services for pharmaceutical and biotechnology companies to accelerate development of new health insights SOUTH SAN FRANCISCO, Calif. and MONTREAL , Jan. 08, 2019 (GLOBE NEWSWIRE) -- Caprion Biosciences, a world-leading specialty contract research organization (CRO) laboratory
View HTML
Toggle Summary Colin McCracken Joins Fluidigm as Chief Commercial Officer
SOUTH SAN FRANCISCO, Calif. , March 05, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Colin McCracken has joined the company as its Chief Commercial Officer. McCracken will be responsible for leading all commercial activities, driving revenue growth in new and
View HTML
Toggle Summary David King Joins Fluidigm as Vice President, Research and Development, Genomics
SOUTH SAN FRANCISCO, Calif. , June 26, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of David King as Vice President, Research and Development, Genomics. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite , King
View HTML
Toggle Summary Dvs Sciences Introduces The Cytof® 2
DVS Sciences introduces the CyTOF® 2 mass cytometer and new MaxPar® Panel Kits for transformational high‐parameter single cell analysis
View HTML
Toggle Summary European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research
SOUTH SAN FRANCISCO, Calif. , May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that leading research institutions in the UK have partnered to acquire and implement seven Helios™ mass cytometry systems to empower life-changing discoveries in human health.
View HTML
Toggle Summary Fluidigm Accelerates Single-Cell Science with the New C1™ Open App™ Program
Program enables researchers to develop new single-cell applications on the C1&#8482 Single-Cell Auto Prep
View HTML
Toggle Summary Fluidigm Adds Gerhard Burbach to Its Board of Directors
Burbach appointed to Fluidigm's Board of Directors
View HTML
Toggle Summary Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China
SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN , China , July 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop molecular diagnostics in China . Under the terms of the partnership, Ascendas Genomics will develop and
View HTML